Shares in Destiny Pharma (LON: DEST) have made a modest recovery following yesterday’s announcement it intended to leave AIM. The largest trade was worth less than £6,000...
Timothy McCutcheon will replace Kirill Golovanov as chief executive of healthcare company Ovoca Bio (LON: OVB) and he has also bought his 19.5 million shares at 0.85p each....
Destiny Pharma PLC (AIM:DEST, OTC:DTTYF) said it is exploring strategic options to advance the development of XF-73 nasal, a breakthrough gel to prevent...
